High levels of stearic acid, palmitoleic acid, and dihomo-γ-linolenic acid and low levels of linoleic acid in serum cholesterol ester are associated with high insulin resistance

Nutrition Research

Volumn 32, Issue 9, 2012, Pages

  Kurotani, Kayo ^a   Sato, Masao ^b   Ejima, Yuko ^b   Nanri, Akiko ^a   Yi, Siyan ^a   Pham, Ngoc Minh ^a   Akter, Shamima ^a   Poudel Tandukar, Kalpana ^c   Kimura, Yasumi ^d   Imaizumi, Katsumi ^b   Mizoue, Tetsuya ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c WASEDA UNIVERSITY   (Japan)

^d FUKUYAMA UNIVERSITY   (Japan)

Author keywords

C peptide; Cholesterol esters; Desaturase; Dihomo linolenic acid; Fatty acids; HOMA; Insulin resistance; Linoleic acid; Palmitoleic acid; Phospholipids

Indexed keywords

C PEPTIDE; CHOLESTEROL ESTER; DESATURASE; DIHOMO GAMMA LINOLENIC ACID; ENZYME; FATTY ACID; GAMMA 5 DESATURASE; GAMMA 6 DESATURASE; GAMMA 9 DESATURASE; GLUCOSE; LINOLEIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID; STEARIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FISH; FOOD INTAKE; GAS LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; JAPANESE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; TREND STUDY;

EID: 84867881261     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.07.004     Document Type: Article

References (33)

1. Kawamori R. Diabetes trends in Japan. Diabetes Metab Res Rev 2002, 18(Suppl. 3):S9-S13.
2. Riccardi G., Giacco R., Rivellese A.A. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004, 23:447-456.
3. Heitmann B.L., Lissner L., Osler M. Do we eat less fat, or just report so?. Int J Obes Relat Metab Disord 2000, 24:435-442.
4. Ma J., Folsom A.R., Shahar E., Eckfeldt J.H. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr 1995, 62:564-571.
5. Patel P.S., Sharp S.J., Jansen E., Luben R.N., Khaw K.T., Wareham N.J., et al. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010, 92:1214-1222.
6. Kotronen A., Velagapudi V.R., Yetukuri L., Westerbacka J., Bergholm R., Ekroos K., et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 2009, 52:684-690.
7. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S., Eckfeldt J.H. ARIC Study Investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003, 78:91-98.
8. Vessby B., Tengblad S., Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994, 37:1044-1050.
9. Pelikanova T., Kazdova L., Chvojkova S., Base J. Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients. Metabolism 2001, 50:1472-1478.
10. Lovejoy J.C., Champagne C.M., Smith S.R., DeLany J.P., Bray G.A., Lefevre M., et al. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. Metabolism 2001, 50:86-92.
11. Corpeleijn E., Feskens E.J., Jansen E.H., Mensink M., Saris W.H., de Bruin T.W., et al. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study. Diabetologia 2006, 49:2392-2401.
12. Hodge A.M., English D.R., O'Dea K., Sinclair A.J., Makrides M., Gibson R.A., et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007, 86:189-197.
13. Mozaffarian D., Cao H., King I.B., Lemaitre R.N., Song X., Siscovick D.S., et al. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 2010, 92:1350-1358.
14. Van Woudenbergh G.J., Kuijsten A., Van der Kallen CJ, Van Greevenbroek M.M., Stehouwer C.D., Blaak E.E., et al. Comparison of fatty acid proportions in serum cholesteryl esters among people with different glucose tolerance status: the CoDAM study. Nutr Metab Cardiovasc Dis 2012, 22(2):133-140.
15. Warensjo E., Rosell M., Hellenius M.L., Vessby B., De Faire U., Riserus U. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis 2009, 8:37.
16. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
17. FAO Statistics Division 2010.
18. Wallin A., Di Giuseppe D., Orsini N., Patel P.S., Forouhi N.G., Wolk A. Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care 2012, 35:918-929.
19. Wahren J., Ekberg K., Johansson J., Henriksson M., Pramanik A., Johansson B.L., et al. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000, 278:E759-E768.
20. Chen C.H., Tsai S.T., Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol 1999, 68:179-186.
21. Stocks T., Lukanova A., Rinaldi S., Biessy C., Dossus L., Lindahl B., et al. Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 2007, 120:2678-2686.
22. Poudel-Tandukar K., Sato M., Ejima Y., Nanri A., Matsushita Y., Imaizumi K., Mizoue T. Relationship of serum fatty acid composition and desaturase activity to C-reactive protein in Japanese men and women. Atherosclerosis 2012, 220(2):520-524.
23. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipid from animal tissues. J Biol Chem 1957, 226:497-509.
24. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
25. Phinney S.D. Fatty acids, inflammation, and the metabolic syndrome. Am J Clin Nutr 2005, 82:1151-1152.
26. Kawashima A., Sugawara S., Okita M., Akahane T., Fukui K., Hashiuchi M., et al. Plasma fatty acid composition, estimated desaturase activities, and intakes of energy and nutrient in Japanese men with abdominal obesity or metabolic syndrome. J Nutr Sci Vitaminol (Tokyo) 2009, 55:400-406.
27. Paton C.M., Ntambi J.M. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab 2009, 297:E28-E37.
28. Devaraj S., Singh U., Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009, 20:182-189.
29. Salmeron J., Hu F.B., Manson J.E., Stampfer M.J., Colditz G.A., Rimm E.B., et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73:1019-1026.
30. Warensjo E., Riserus U., Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005, 48:1999-2005.
31. Djousse L., Biggs M.L., Lemaitre R.N., King I.B., Song X., Ix J.H., et al. Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr 2011, 94:527-533.
32. Santamarina-Fojo S., Lambert G., Hoeg J.M., Brewer H.B. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 2000, 11:267-275.
33. Kaaks R., Toniolo P., Akhmedkhanov A., Lukanova A., Biessy C., Dechaud H., et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000, 92:1592-1600.